[1]朱双双,李仕永,汤 宇,等.清热散结胶囊对流行性角结膜炎患者视力、泪膜稳定性及泪液蛋白水平的影响[J].陕西中医,2024,(5):642-645.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.015]
 ZHU Shuangshuang,LI Shiyong,TANG Yu,et al.The effects of Qingre Sanjie capsules on vision,tear film stability,and tear protein levels in patients with epidemic keratoconjunctivitis[J].,2024,(5):642-645.[doi:DOI:10.3969/j.issn.1000-7369.2024.05.015]
点击复制

清热散结胶囊对流行性角结膜炎患者视力、泪膜稳定性及泪液蛋白水平的影响

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年5期
页码:
642-645
栏目:
临床研究
出版日期:
2024-05-05

文章信息/Info

Title:
The effects of Qingre Sanjie capsules on vision,tear film stability,and tear protein levels in patients with epidemic keratoconjunctivitis
作者:
朱双双李仕永汤 宇程 婉
(南京医科大学第四附属医院眼科,江苏 南京 210031)
Author(s):
ZHU ShuangshuangLI ShiyongTANG YuCHENG Wan
(Department of Ophthalmology,Fourth Affiliated Hospital of Nanjing Medical University,Nanjing 210031,China)
关键词:
流行性角结膜炎 清热散结胶囊 更昔洛韦眼用凝胶 中医证候 视力 泪膜稳定性 复发
Keywords:
Epidemic keratoconjunctivitis Qingre Sanjie capsules Ganciclovir eye gel Traditional Chinese medicine symptoms Vision Tear film stability Recurrence
分类号:
R 773.31
DOI:
DOI:10.3969/j.issn.1000-7369.2024.05.015
文献标志码:
A
摘要:
目的:探讨清热散结胶囊对流行性角结膜炎患者视力、泪膜稳定性及泪液蛋白水平的影响。方法:随机将316例流行性角结膜炎患者纳入对照组和试验组,各158例。对照组给予更昔洛韦眼用凝胶进行治疗,试验组在此基础上加用清热散结胶囊,两组均治疗2周,并随访6个月。比较两组疗效、中医证候、眼表功能、视力情况、泪膜稳定性、泪液蛋白水平、不良反应及复发情况。结果:试验组治疗2周后的总有效率高于对照组(P<0.05)。治疗2周后与治疗前比,两组中医证候、眼表疾病指数(OSDI)、泪膜破裂时间(BUT)、泪液分泌量(SIT)、角膜荧光素染色(FL)评分降低,试验组更低(P<0.05); 两组视力及泪液乳铁蛋白(LF)、总蛋白(TP)、分泌型免疫球蛋白A(sIgA)、溶菌酶(LZM)水平升高,试验组更高(P<0.05)。两组治疗期间的并发症总发生率比较无统计学差异(P>0.05); 试验组随访期间的复发率为1.90%,低于对照组的12.03%(P<0.05)。结论:流行性角结膜炎患者经清热散结胶囊治疗后其泪液蛋白水平得到有效调节,中医证候、眼表功能、视力情况及泪膜稳定性得到有效改善,疗效提高,且复发风险降低,安全性良好。
Abstract:
Objective:To investigate the effects of Qingre Sanjie capsules on vision,tear film stability,and tear protein levels in patients with epidemic keratoconjunctivitis.Methods:316 patients with epidemic keratoconjunctivitis were randomly divided into the control group(158 cases)and the experimental group(158 cases).The control group was treated with ganciclovir eye gel,and the experimental group was treated with Qingre Sanjie capsule on the basis of the control group.Both groups were treated for 2 weeks and followed up for 6 months.The curative effect,traditional Chinese medicine symptoms,ocular surface function,visual acuity,tear film stability,level of tear protein,adverse reaction and recurrence were compared between the two groups.Results:The total effective rate of experimental was higher than control(P<0.05).Compared to before,after 2 weeks of treatment,the traditional Chinese medicine syndrome scores,eye surface index(OSDI),tear film rupture time(BUT),tear secretion volume(SIT),and corneal fluorescence staining(FL)of the two groups decreased,experimental group was lower(P<0.05).The levels of visual acuity,tear lactoferrin(LF),total protein(TP),secretory immunoglobulin A(sIgA),and lysozyme(LZM)in the two groups increased,experimental group was higher(P<0.05).The total incidence of complications during the treatment period in two groups was no significant difference(P>0.05).The recurrence rate during the followed up period in experimental group was 1.90%,lower than the 12.03% in control group(P<0.05).Conclusion:After treatment with Qingre Sanjie capsules,patients with epidemic keratoconjunctivitis has effectively regulated their tear protein levels,improved traditional Chinese medicine syndromes,ocular surface function,visual acuity,and tear film stability.The therapeutic effect is increased,and the risk of recurrence is reduced,with good safety.

参考文献/References:

[1] HASHIZUME M,AOKI K,OHNO S,et al.Disinfectant potential in inactivation of epidemic keratoconjunctivitis-related adenoviruses by potassium peroxymonosulfate[J].Eur J Ophthalmol,2021,31(2):379-384.
[2] LIU P,LI G,HAN M,et al.Efficacy and safety of ophthalmic preparations of glucocorticoids in patients with epidemic keratoconjunctivitis:A systematic review and Meta-analysis[J].Ther Innov Regul Sci,2023,57(3):476-483.
[3] 吉成玉.龙胆泻肝汤联合更昔洛韦眼用凝胶治疗单纯疱疹病毒性角膜炎的疗效分析[J].中国现代药物应用,2020,14(22):230-231.
[4] 王维萌,孔凡女,王玉安.明目蒺藜丸联合更昔洛韦眼用凝胶治疗流行性角结膜炎的疗效观察[J].现代药物与临床,2019,34(2):513-516.
[5] 黄滟凌,刘洪科.清热散结胶囊联合更昔洛韦眼用凝胶治疗流行性角结膜炎的临床研究[J].中国医院用药评价与分析,2020,20(6):660-662,666.
[6] 葛坚.眼科学[M].2版.北京:人民卫生出版社,2010:52-53.
[7] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:178-180.
[8] 林晨,杨敏敏,郑虔.眼表疾病指数量表中文版的研制和性能评价[J].眼科新进展,2013,33(1):38-40.
[9] 李洪霞.国际标准视力表[M].南昌:江西科学技术出版社,2010:55-58.
[10] 张光红,李小玉,李杜军,等.穴位注射辅助治疗单纯疱疹病毒性角膜炎恢复期干眼疗效观察[J].中国针灸,2020,40(10):1081-1084.
[11] MULLER M P,SIDDIQUI N,IVANCIC R,et al.Adenovirus-related epidemic keratoconjunctivitis outbreak at a hospital-affiliated ophthalmology clinic[J].Am J Infect Control,2018,46(5):581-583.
[12] 安致稳,阴雅男,李卓,等.子午流注针法联合中药熏蒸治疗水样液缺乏性干眼症疗效研究[J].陕西中医,2023,44(9):1297-1301.
[13] GOUIDER D,KHALLOULI A,MAALEJ A,et al.Role of anterior segment optical coherence tomography in monitoring epidemic keratoconjunctivitis[J].J Curr Ophthalmol,2022,33(4):408-412.
[14] 马文婷,赵铭,王升,等.自体血清联合玻璃酸钠治疗白内障术后干眼症疗效及对患者泪液炎症因子的影响[J].陕西医学杂志,2022,51(9):1129-1132.
[15] LEDBETTER E C,BADANES Z I,CHAN R X,et al.Comparative efficacy of topical ophthalmic ganciclovir and oral famciclovir in cats with experimental ocular feline herpesvirus-1 epithelial infection[J].J Ocul Pharmacol Ther,2022,38(5):339-347.
[16] 吴亭彧,李凤荣.当归饮子加减治疗难治性春季角结膜炎验案1例[J].中国中医眼科杂志,2022,32(8):646-647.
[17] 栗艳萍,刘声.决明子热敷辅助治疗春季角结膜炎的临床观察[J].山西医药杂志,2017,46(17):2067-2069.
[18] 陆雪群,陈冲达,龚梁.清热散结片对流行性角结膜炎的中医证候疗效及泪液蛋白影响分析[J].中华中医药学刊,2019,37(2):457-459.
[19] NANDI S K,SINGH D,UPADHAY J,et al.Identification of tear-based protein and non-protein biomarkers:Its application in diagnosis of human diseases using biosensors[J].Int J Biol Macromol,2021,193(1):838-846.
[20] 苏丽萍,刘郡,王珏.湿房镜联合氟米龙滴眼液治疗干眼症疗效及对患者泪膜稳定性和血清基质金属蛋白酶-2的影响[J].陕西医学杂志,2022,51(5):586-590.
[21] 胡文静,沈红良,张萌,等.干眼症小鼠泪液中胸腺基质淋巴细胞生成素和白介素18水平变化及相关机制研究[J].陕西医学杂志,2021,50(11):1333-1335,1344.
[22] GIJS M,ARUMUGAM S,VAN DE SANDE N,et al.Pre-analytical sample handling effects on tear fluid protein levels[J].Sci Rep,2023,13(1):1317-1318.
[23] RITCHOO S,HAVANAPAN P O,PHUNGTHANOM N,et al.Analysis and comparison of tear protein profiles in dogs using different tear collection methods[J].BMC Vet Res,2022,18(1):442-444.
[24] 应志翔,王若洁.中西医结合治疗流行性角结膜炎的临床观察[J].中国中医急症,2017,26(7):1269-1271.
[25] 庞有慧.疏风解毒胶囊治疗流行性角结膜炎的临床观察[J].中华中医药杂志,2017,32(1):366-368.
[26] 姚锋.疏风解毒胶囊治疗流行性角结膜炎临床观察[J].中国中医急症,2017,26(10):1865-1867.
[27] 赵文楠,周朝忠,吴志平,等.清热散结胶囊体外和体内抗菌活性研究[J].中成药,2023,45(8):2747-2751.

备注/Memo

备注/Memo:
基金项目:中国中医药研究促进会科研项目(2022033)
更新日期/Last Update: 2024-05-09